Cargando…
Novel Drugs for the Management of Diabetes Kidney Transplant Patients: A Literature Review
The management of diabetes and renal failure is changing thanks to the appearance of new drugs such as glucagon-like peptide 1 receptor agonists (GLP1-RA) and sodium-glucose cotransporter type 2 inhibitors (SGLT2i) that have benefits in terms of survival and cardiorenal protection. Based on the pote...
Autores principales: | Valencia-Morales, Nancy Daniela, Rodríguez-Cubillo, Beatriz, Loayza-López, Rómulo Katsu, Moreno de la Higuera, Maria Ángeles, Sánchez-Fructuoso, Ana Isabel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10304316/ https://www.ncbi.nlm.nih.gov/pubmed/37374048 http://dx.doi.org/10.3390/life13061265 |
Ejemplares similares
-
Impacts of Interleukin-18 Polymorphisms on the Incidence of Delayed-Onset Cytomegalovirus Infection in a Cohort of Kidney Transplant Recipients
por: Pérez-Flores, Isabel, et al.
Publicado: (2019) -
Role of mTOR inhibitor in the cellular and humoral immune response to a booster dose of SARS-CoV-2 mRNA-1273 vaccine in kidney transplant recipients
por: Pérez-Flores, Isabel, et al.
Publicado: (2023) -
The Interferon-Gamma +874 A/T Polymorphism Is Not Associated With CMV Infection After Kidney Transplantation
por: Santiago, Jose Luis, et al.
Publicado: (2020) -
Association of Polymorphisms in T-Cell Activation Costimulatory/Inhibitory Signal Genes With Allograft Kidney Rejection Risk
por: Santiago, Jose Luis, et al.
Publicado: (2021) -
The Polymorphism −308G/A of Tumor Necrosis Factor-α Gene Modulates the Effect of Immunosuppressive Treatment in First Kidney Transplant Subjects Who Suffer an Acute Rejection
por: Sánchez-Fructuoso, Ana Isabel, et al.
Publicado: (2016)